Which hedge funds own LKFT? LAKEFRONT BIOTHERAPEUTICS NV, Q2 2026 13F holders
HealthcareBiotechnologyFollow
15 tracked hedge funds disclosed a position in LKFT (LAKEFRONT BIOTHERAPEUTICS NV) in their Q2 2026 13F filings, worth $272.6m in total. The largest holder by portfolio weight is Prosight Management, LP at 10.6% of its book. 2 opened a new position this quarter: Schonfeld Strategic Advisors LLC, Marshall Wace, LLP. 3 exited: Hudson Bay Capital Management LP, Voloridge Investment Management, LLC, Squarepoint Ops LLC.
15
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
2
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
3
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$1.9m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$3.1m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$273m
Combined value
Sum of the holders' reported positions in the security.
1.2%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.